167 related articles for article (PubMed ID: 3283094)
1. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
4. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
5. Aztreonam.
Tunkel AR; Scheld WM
Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
[TBL] [Abstract][Full Text] [Related]
6. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
Marco V; Gobernado M; Santos M; Rabinad E
Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
Simons WJ; Lee TJ
Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
[TBL] [Abstract][Full Text] [Related]
11. Treatment of serious gram-negative infections with aztreonam.
Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycosides, imipenem, and aztreonam.
Johnson JG; Hardin TC
Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
Clergeot A; Steru D; Rosset MA; Carbon C
J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of aztreonam in refractory infections in children].
Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
16. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
18. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
19. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
Cook JL
Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
[TBL] [Abstract][Full Text] [Related]
20. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
Hellinger WC; Brewer NS
Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]